|
EP300-AS1 expression profile based on
|
*
Please note that low number(<10) of normal samples considered.
PAAD : Pancreatic adenocarcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.488008E-01 |
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.029247E-01 |
| Normal-vs-Stage2 |
8.302458E-01 |
| Normal-vs-Stage3 |
4.881640E-01 |
| Normal-vs-Stage4 |
9.315932E-01 |
| Stage1-vs-Stage2 |
8.022586E-01 |
| Stage1-vs-Stage3 |
2.027213E-01 |
| Stage1-vs-Stage4 |
7.724525E-01 |
| Stage2-vs-Stage3 |
2.106178E-01 |
| Stage2-vs-Stage4 |
6.691648E-01 |
| Stage3-vs-Stage4 |
3.110771E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.639373E-01 |
| Normal-vs-AfricanAmerican |
7.083165E-01 |
| Normal-vs-Asian |
9.684506E-01 |
| Caucasian-vs-AfricanAmerican |
6.852210E-01 |
| Caucasian-vs-Asian |
7.771403E-01 |
| AfricanAmerican-vs-Asian |
6.108347E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.790935E-01 |
| Normal-vs-Female |
9.365914E-01 |
| Male-vs-Female |
2.467328E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.183852E-01 |
| Normal-vs-Age(41-60Yrs) |
7.777435E-01 |
| Normal-vs-Age(61-80Yrs) |
9.114790E-01 |
| Normal-vs-Age(81-100Yrs) |
7.358878E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.998060E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.157740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.381284E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.663391E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.295992E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.802885E-01 |
|
|
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade1 |
8.729153E-01 |
| Normal-vs-Grade2 |
9.420869E-01 |
| Normal-vs-Grade3 |
6.960874E-01 |
| Normal-vs-Grade4 |
1.967862E-01 |
| Grade1-vs-Grade2 |
7.612382E-01 |
| Grade1-vs-Grade3 |
4.511175E-01 |
| Grade1-vs-Grade4 |
1.016948E-02 |
| Grade2-vs-Grade3 |
6.235288E-02 |
| Grade2-vs-Grade4 |
4.998492E-02 |
| Grade3-vs-Grade4 |
6.483589E-02 |
|
|
